400-920-2911 sales@csnpharm.cn
您的位置 : 首页 / Cytoskeleton / FAK / Benzene-1,2,4,5-tetraamine tetrahydrochloride
CAS No.: 4506-66-5
Synonyms: FAK Inhibitor 14;FAK Inhibitor Y15;Focal Adhesion Kinase Inhibitor 14
Y15 is a small molecule FAK phosphorylation inhibitor which specifically block phosphorylation of Y397-FAK and total phosphorylation of FAK.
生物活性
NCT号 | 适应症或疾病 | 临床期 | 招募状态 | 预计完成时间 | 地点 |
---|---|---|---|---|---|
NCT00289757 | Hepatitis A | Phase 4 | Completed | - | Belgium ... more >> GSK Investigational Site Wilrijk, Belgium, 2610 Collapse << |
NCT00289770 | - | - | Completed | - | - |
NCT00289757 | - | - | Completed | - | - |
实验方案
技术信息
CAS号 | 4506-66-5 | 储存条件 |
|
|||||
分子式 | C6H14Cl4N4 | 运输 | 蓝冰 | |||||
分子量 | 284.01 | 别名 | FAK Inhibitor 14;FAK Inhibitor Y15;Focal Adhesion Kinase Inhibitor 14;NSC 667249;NSC 677249 | |||||
溶解度 |
|
动物实验配方 |
NCT号 | 适应症或疾病 | 临床期 | 招募状态 | 预计完成时间 | 地点 |
---|
NCT00289757 | Hepatitis A | Phase 4 | Completed | - | Belgium ... more >> GSK Investigational Site Wilrijk, Belgium, 2610 Collapse << |
NCT00289770 | - | - | Completed | - | - |
NCT00289757 | - | - | Completed | - | - |
NCT00289770 | Hepatitis B H... more >>epatitis A Collapse << | Phase 3 | Completed | - | Belgium ... more >> GSK Investigational Site Wilrijk, Belgium, 2610 Collapse << |
NCT00289718 | Hepatitis B H... more >>epatitis A Collapse << | Phase 3 | Completed | - | Belgium ... more >> GSK Investigational Site Gent, Belgium, 9000 Collapse << |
NCT00289718 | - | - | Completed | - | - |
NCT02037230 | Adenocarcinoma of the Pancreas | Phase 1 Phase 2 | Active, not recruiting | January 2022 | United States, Michigan ... more >> University of Michigan Hospital Ann Arbor, Michigan, United States, 48109 Collapse << |
NCT02543541 | Cancer | Not Applicable | Active, not recruiting | December 2018 | United States, Ohio ... more >> Case Comprehensive Cancer Center Cleveland, Ohio, United States, 44106 Collapse << |
NCT02666183 | Advanced Cancer | Not Applicable | Recruiting | June 2019 | United States, Ohio ... more >> University Hospitals Cleveland Medical Center, Case Comprehensive Cancer Center Recruiting Cleveland, Ohio, United States, 44106 Contact: Sara Douglas, RN, PhD 216-368-0702 sld4@case.edu Principal Investigator: Sara Douglas, RN, PhD Collapse << |
靶点 | Description | IC50 |
---|
联系我们
官方电话:400-920-2911
二维码
微信公众号 CSN官网